| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fat Emulsions, Intravenous | 61 | 2022 | 314 | 10.810 |
Why?
|
| Parenteral Nutrition | 83 | 2022 | 640 | 10.650 |
Why?
|
| Fish Oils | 51 | 2022 | 454 | 7.390 |
Why?
|
| Intestinal Diseases | 21 | 2022 | 507 | 4.590 |
Why?
|
| Soybean Oil | 29 | 2022 | 131 | 4.470 |
Why?
|
| Liver Diseases | 28 | 2022 | 1246 | 4.040 |
Why?
|
| Cholestasis | 25 | 2022 | 354 | 3.530 |
Why?
|
| Short Bowel Syndrome | 19 | 2022 | 296 | 2.350 |
Why?
|
| Enteral Nutrition | 23 | 2022 | 725 | 1.870 |
Why?
|
| Fatty Acids, Essential | 16 | 2020 | 95 | 1.810 |
Why?
|
| Parenteral Nutrition, Total | 13 | 2022 | 310 | 1.790 |
Why?
|
| Parenteral Nutrition Solutions | 10 | 2021 | 28 | 1.440 |
Why?
|
| Aluminum | 4 | 2017 | 137 | 1.360 |
Why?
|
| Pharmacy Service, Hospital | 3 | 2019 | 133 | 0.980 |
Why?
|
| Nutritional Requirements | 5 | 2019 | 289 | 0.940 |
Why?
|
| Fatty Acids, Omega-3 | 15 | 2019 | 1267 | 0.850 |
Why?
|
| Dietary Fats | 11 | 2019 | 2042 | 0.840 |
Why?
|
| Parenteral Nutrition, Home | 5 | 2021 | 29 | 0.770 |
Why?
|
| Drug Contamination | 2 | 2014 | 151 | 0.760 |
Why?
|
| Growth | 3 | 2020 | 393 | 0.760 |
Why?
|
| Deficiency Diseases | 3 | 2017 | 73 | 0.710 |
Why?
|
| Triglycerides | 17 | 2021 | 2564 | 0.710 |
Why?
|
| Bilirubin | 10 | 2017 | 392 | 0.700 |
Why?
|
| Intestines | 7 | 2022 | 1929 | 0.700 |
Why?
|
| Infant Nutritional Physiological Phenomena | 7 | 2021 | 325 | 0.670 |
Why?
|
| Infant Nutrition Disorders | 1 | 2017 | 82 | 0.640 |
Why?
|
| Liver Failure | 5 | 2022 | 233 | 0.640 |
Why?
|
| Infant | 45 | 2022 | 34261 | 0.620 |
Why?
|
| Child Nutritional Physiological Phenomena | 2 | 2017 | 303 | 0.610 |
Why?
|
| Dietary Supplements | 10 | 2017 | 3025 | 0.590 |
Why?
|
| Micronutrients | 3 | 2017 | 362 | 0.580 |
Why?
|
| Nutritional Status | 6 | 2022 | 1532 | 0.580 |
Why?
|
| Catheter-Related Infections | 6 | 2020 | 239 | 0.570 |
Why?
|
| Child Nutrition Disorders | 1 | 2017 | 171 | 0.570 |
Why?
|
| Fatty Liver | 10 | 2019 | 718 | 0.560 |
Why?
|
| Gastrointestinal Diseases | 4 | 2019 | 1148 | 0.550 |
Why?
|
| Malabsorption Syndromes | 3 | 2019 | 141 | 0.520 |
Why?
|
| Infant, Premature | 8 | 2021 | 1989 | 0.520 |
Why?
|
| Infant, Premature, Diseases | 6 | 2021 | 700 | 0.500 |
Why?
|
| Infant, Newborn | 33 | 2022 | 24433 | 0.500 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2019 | 720 | 0.490 |
Why?
|
| Infant, Very Low Birth Weight | 3 | 2021 | 423 | 0.480 |
Why?
|
| Swimming | 1 | 2013 | 201 | 0.470 |
Why?
|
| Critical Illness | 6 | 2022 | 2496 | 0.440 |
Why?
|
| Docosahexaenoic Acids | 8 | 2017 | 846 | 0.430 |
Why?
|
| Child Development | 4 | 2019 | 2177 | 0.430 |
Why?
|
| Drug Compounding | 5 | 2020 | 245 | 0.420 |
Why?
|
| Catheterization, Central Venous | 6 | 2020 | 511 | 0.380 |
Why?
|
| Aspartate Aminotransferases | 4 | 2020 | 413 | 0.380 |
Why?
|
| alpha-Tocopherol | 3 | 2019 | 131 | 0.380 |
Why?
|
| Food, Formulated | 1 | 2010 | 116 | 0.380 |
Why?
|
| Fatty Acids | 9 | 2022 | 1741 | 0.380 |
Why?
|
| Energy Intake | 8 | 2020 | 2136 | 0.360 |
Why?
|
| Arachidonic Acid | 5 | 2017 | 436 | 0.340 |
Why?
|
| Protective Agents | 2 | 2019 | 164 | 0.330 |
Why?
|
| Child | 39 | 2022 | 73636 | 0.330 |
Why?
|
| Intestinal Absorption | 3 | 2019 | 437 | 0.320 |
Why?
|
| Medication Errors | 4 | 2017 | 772 | 0.320 |
Why?
|
| Humans | 119 | 2022 | 708843 | 0.320 |
Why?
|
| Phytosterols | 4 | 2019 | 58 | 0.300 |
Why?
|
| Bone Diseases, Metabolic | 3 | 2014 | 398 | 0.300 |
Why?
|
| Catheterization, Peripheral | 1 | 2009 | 359 | 0.290 |
Why?
|
| Child, Preschool | 20 | 2020 | 41081 | 0.290 |
Why?
|
| Hyperlipidemias | 1 | 2010 | 796 | 0.280 |
Why?
|
| Practice Guidelines as Topic | 9 | 2021 | 7487 | 0.270 |
Why?
|
| Hypertriglyceridemia | 1 | 2007 | 292 | 0.270 |
Why?
|
| Plant Oils | 5 | 2016 | 189 | 0.260 |
Why?
|
| Enterocolitis, Necrotizing | 3 | 2012 | 336 | 0.260 |
Why?
|
| Drug Incompatibility | 2 | 2021 | 11 | 0.260 |
Why?
|
| Infant, Low Birth Weight | 3 | 2012 | 833 | 0.250 |
Why?
|
| Alanine Transaminase | 4 | 2018 | 600 | 0.250 |
Why?
|
| Liver | 13 | 2022 | 7622 | 0.250 |
Why?
|
| Phospholipids | 6 | 2013 | 813 | 0.240 |
Why?
|
| Alkaline Phosphatase | 3 | 2017 | 892 | 0.240 |
Why?
|
| Linoleic Acid | 3 | 2017 | 131 | 0.230 |
Why?
|
| Liver Function Tests | 4 | 2014 | 533 | 0.210 |
Why?
|
| Male | 59 | 2022 | 349524 | 0.200 |
Why?
|
| Nursing Staff, Hospital | 1 | 2004 | 335 | 0.200 |
Why?
|
| Disease Models, Animal | 19 | 2022 | 18375 | 0.200 |
Why?
|
| Refeeding Syndrome | 1 | 2020 | 13 | 0.200 |
Why?
|
| Antithrombins | 1 | 2022 | 294 | 0.190 |
Why?
|
| Drug Evaluation | 1 | 2021 | 661 | 0.190 |
Why?
|
| Pharmacists | 2 | 2019 | 220 | 0.190 |
Why?
|
| Lipids | 5 | 2012 | 3246 | 0.190 |
Why?
|
| Liver Transplantation | 4 | 2020 | 2022 | 0.190 |
Why?
|
| Liver Cirrhosis | 4 | 2015 | 1721 | 0.190 |
Why?
|
| Treatment Outcome | 18 | 2021 | 61932 | 0.180 |
Why?
|
| Recovery of Function | 1 | 2010 | 2950 | 0.180 |
Why?
|
| Hospitals, Pediatric | 5 | 2016 | 1776 | 0.180 |
Why?
|
| Product Labeling | 1 | 2019 | 85 | 0.180 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2021 | 286 | 0.170 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2015 | 5135 | 0.170 |
Why?
|
| Latex | 1 | 1997 | 61 | 0.170 |
Why?
|
| Endotoxemia | 1 | 2019 | 219 | 0.170 |
Why?
|
| Nutrition Assessment | 2 | 2020 | 714 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 17 | 2022 | 22989 | 0.170 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2017 | 129 | 0.160 |
Why?
|
| Retrospective Studies | 22 | 2022 | 71483 | 0.160 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2018 | 145 | 0.160 |
Why?
|
| United States Food and Drug Administration | 3 | 2014 | 1740 | 0.160 |
Why?
|
| Gastrointestinal Hemorrhage | 3 | 2016 | 1055 | 0.160 |
Why?
|
| Vitamin K | 1 | 2019 | 283 | 0.160 |
Why?
|
| Nutritional Support | 2 | 2022 | 170 | 0.160 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 1997 | 291 | 0.150 |
Why?
|
| Infection Control | 1 | 2004 | 959 | 0.150 |
Why?
|
| Hepatic Insufficiency | 1 | 2016 | 13 | 0.150 |
Why?
|
| Mucolipidoses | 2 | 2019 | 78 | 0.150 |
Why?
|
| Case-Control Studies | 4 | 2020 | 21194 | 0.150 |
Why?
|
| Energy Metabolism | 4 | 2012 | 2968 | 0.150 |
Why?
|
| Emulsions | 5 | 2014 | 147 | 0.150 |
Why?
|
| Female | 42 | 2021 | 375205 | 0.150 |
Why?
|
| Feeding Methods | 1 | 2016 | 34 | 0.150 |
Why?
|
| Pruritus | 1 | 2019 | 334 | 0.150 |
Why?
|
| Rest | 2 | 2012 | 868 | 0.150 |
Why?
|
| Animals | 37 | 2022 | 170486 | 0.140 |
Why?
|
| PPAR gamma | 1 | 2019 | 491 | 0.140 |
Why?
|
| Medication Reconciliation | 1 | 2017 | 157 | 0.140 |
Why?
|
| Intestine, Small | 1 | 2022 | 1235 | 0.140 |
Why?
|
| Environmental Exposure | 1 | 2010 | 3954 | 0.140 |
Why?
|
| Dietary Proteins | 1 | 2020 | 967 | 0.140 |
Why?
|
| Heparin | 1 | 2022 | 1625 | 0.140 |
Why?
|
| Patient Transfer | 1 | 2022 | 759 | 0.140 |
Why?
|
| Gastric Emptying | 1 | 2017 | 229 | 0.140 |
Why?
|
| Vitamin E | 1 | 2019 | 842 | 0.130 |
Why?
|
| Cross Infection | 1 | 2004 | 1412 | 0.130 |
Why?
|
| Disease Outbreaks | 1 | 2004 | 1709 | 0.130 |
Why?
|
| Weight Gain | 5 | 2020 | 2193 | 0.130 |
Why?
|
| Hair | 1 | 2017 | 445 | 0.130 |
Why?
|
| Citrulline | 1 | 2014 | 106 | 0.130 |
Why?
|
| Ileum | 1 | 2017 | 558 | 0.130 |
Why?
|
| Postoperative Care | 2 | 2018 | 1514 | 0.130 |
Why?
|
| United States | 17 | 2022 | 67165 | 0.130 |
Why?
|
| Sterilization | 1 | 2014 | 136 | 0.120 |
Why?
|
| Mucositis | 1 | 2014 | 100 | 0.120 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2014 | 229 | 0.120 |
Why?
|
| Malnutrition | 2 | 2016 | 620 | 0.120 |
Why?
|
| Fatty Acids, Omega-6 | 3 | 2013 | 224 | 0.120 |
Why?
|
| Stomach | 1 | 2017 | 673 | 0.120 |
Why?
|
| Medication Systems, Hospital | 1 | 1993 | 160 | 0.110 |
Why?
|
| Body Fluid Compartments | 1 | 2011 | 51 | 0.110 |
Why?
|
| Infusions, Intravenous | 2 | 2016 | 2303 | 0.110 |
Why?
|
| Hyperbilirubinemia | 2 | 2016 | 71 | 0.110 |
Why?
|
| Bacteremia | 2 | 2015 | 968 | 0.110 |
Why?
|
| Gastrointestinal Tract | 2 | 2016 | 834 | 0.110 |
Why?
|
| Health Care Rationing | 1 | 2015 | 455 | 0.110 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 1194 | 0.110 |
Why?
|
| Mouth Mucosa | 1 | 2014 | 431 | 0.110 |
Why?
|
| Adolescent | 15 | 2020 | 84718 | 0.100 |
Why?
|
| Lipid Regulating Agents | 1 | 2010 | 25 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2020 | 9488 | 0.100 |
Why?
|
| Maximum Allowable Concentration | 1 | 2010 | 59 | 0.100 |
Why?
|
| Reperfusion Injury | 1 | 2018 | 1071 | 0.100 |
Why?
|
| Cysteine | 1 | 2015 | 861 | 0.100 |
Why?
|
| Interleukin-6 | 4 | 2019 | 3179 | 0.100 |
Why?
|
| Inflammation | 3 | 2019 | 10019 | 0.100 |
Why?
|
| Mice | 20 | 2022 | 80876 | 0.100 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2012 | 530 | 0.100 |
Why?
|
| Age Factors | 5 | 2019 | 18712 | 0.100 |
Why?
|
| Prospective Studies | 13 | 2021 | 50597 | 0.100 |
Why?
|
| Health | 1 | 2012 | 395 | 0.090 |
Why?
|
| Vaccines | 1 | 2017 | 719 | 0.090 |
Why?
|
| Growth Disorders | 1 | 2014 | 641 | 0.090 |
Why?
|
| Hypersensitivity | 1 | 1997 | 1019 | 0.090 |
Why?
|
| Food Contamination | 1 | 2010 | 167 | 0.090 |
Why?
|
| C-Reactive Protein | 5 | 2020 | 3696 | 0.090 |
Why?
|
| Adult | 17 | 2021 | 211041 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 1805 | 0.090 |
Why?
|
| Eicosapentaenoic Acid | 4 | 2017 | 535 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 3 | 2020 | 6991 | 0.090 |
Why?
|
| Osmolar Concentration | 1 | 2009 | 711 | 0.090 |
Why?
|
| Insulin Resistance | 1 | 2022 | 3866 | 0.090 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2010 | 234 | 0.080 |
Why?
|
| Streptomyces | 2 | 1997 | 86 | 0.080 |
Why?
|
| Biliary Tract | 1 | 2008 | 139 | 0.080 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 2340 | 0.080 |
Why?
|
| Probability | 2 | 2014 | 2474 | 0.080 |
Why?
|
| Family | 1 | 2018 | 3087 | 0.080 |
Why?
|
| Risk Factors | 9 | 2020 | 69553 | 0.080 |
Why?
|
| Glutamine | 2 | 2012 | 567 | 0.080 |
Why?
|
| Serum Albumin | 1 | 2009 | 681 | 0.080 |
Why?
|
| Swine | 3 | 2022 | 5763 | 0.070 |
Why?
|
| Bone and Bones | 2 | 2014 | 2567 | 0.070 |
Why?
|
| Drug Prescriptions | 1 | 2016 | 1662 | 0.070 |
Why?
|
| Metabolome | 1 | 2013 | 859 | 0.070 |
Why?
|
| Intestinal Volvulus | 1 | 2006 | 55 | 0.070 |
Why?
|
| Incidence | 6 | 2022 | 20320 | 0.070 |
Why?
|
| Glucose | 4 | 2017 | 4261 | 0.070 |
Why?
|
| Electrolytes | 3 | 2017 | 289 | 0.070 |
Why?
|
| Immunity | 1 | 2012 | 957 | 0.070 |
Why?
|
| Vitamins | 3 | 2022 | 1466 | 0.070 |
Why?
|
| Dietary Carbohydrates | 2 | 2012 | 902 | 0.070 |
Why?
|
| Cholecystitis, Acute | 1 | 2006 | 65 | 0.070 |
Why?
|
| Microvilli | 2 | 2019 | 249 | 0.070 |
Why?
|
| Anemia | 1 | 2014 | 1403 | 0.070 |
Why?
|
| Societies, Scientific | 2 | 2018 | 212 | 0.070 |
Why?
|
| Ceftriaxone | 1 | 2006 | 149 | 0.070 |
Why?
|
| Patient Discharge | 1 | 2018 | 2980 | 0.070 |
Why?
|
| Consumer Product Safety | 1 | 2006 | 130 | 0.070 |
Why?
|
| Statistics, Nonparametric | 2 | 2009 | 2945 | 0.070 |
Why?
|
| Osteoporosis | 1 | 2015 | 1556 | 0.070 |
Why?
|
| Hypoglycemia | 1 | 2011 | 805 | 0.070 |
Why?
|
| Body Composition | 2 | 2011 | 2393 | 0.070 |
Why?
|
| Vitamin D Deficiency | 1 | 2015 | 1356 | 0.070 |
Why?
|
| Clinical Competence | 2 | 2018 | 4615 | 0.070 |
Why?
|
| PPAR alpha | 1 | 2006 | 192 | 0.070 |
Why?
|
| Amino Acids | 3 | 2017 | 1752 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2019 | 6255 | 0.070 |
Why?
|
| Metabolomics | 1 | 2013 | 1357 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 5348 | 0.070 |
Why?
|
| Cholelithiasis | 1 | 2006 | 416 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2244 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 1948 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2019 | 23284 | 0.060 |
Why?
|
| Ethanol | 1 | 2010 | 1245 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 3690 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2011 | 1343 | 0.060 |
Why?
|
| Hydroxamic Acids | 1 | 2006 | 507 | 0.060 |
Why?
|
| Double-Blind Method | 6 | 2015 | 11877 | 0.060 |
Why?
|
| Dyslipidemias | 1 | 2010 | 843 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2004 | 293 | 0.060 |
Why?
|
| Blood Platelets | 1 | 2013 | 2485 | 0.060 |
Why?
|
| Adipose Tissue | 2 | 2011 | 3234 | 0.060 |
Why?
|
| Radiotherapy | 1 | 2010 | 1623 | 0.060 |
Why?
|
| Graft vs Host Disease | 1 | 2014 | 2818 | 0.060 |
Why?
|
| Bone Density | 1 | 2015 | 3395 | 0.050 |
Why?
|
| Consensus | 2 | 2021 | 2713 | 0.050 |
Why?
|
| Cell Membrane | 3 | 2012 | 3892 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15252 | 0.050 |
Why?
|
| Equipment Design | 1 | 2009 | 3627 | 0.050 |
Why?
|
| Area Under Curve | 2 | 2017 | 1688 | 0.050 |
Why?
|
| Living Donors | 1 | 2005 | 569 | 0.050 |
Why?
|
| Safety | 1 | 2005 | 1224 | 0.050 |
Why?
|
| Reference Values | 1 | 2008 | 5041 | 0.050 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2022 | 311 | 0.050 |
Why?
|
| Parents | 1 | 2013 | 3154 | 0.050 |
Why?
|
| Length of Stay | 3 | 2020 | 6257 | 0.050 |
Why?
|
| Young Adult | 5 | 2020 | 55940 | 0.050 |
Why?
|
| Prescriptions | 1 | 2022 | 335 | 0.050 |
Why?
|
| Diet | 3 | 2012 | 7392 | 0.050 |
Why?
|
| Infant Formula | 1 | 2020 | 202 | 0.050 |
Why?
|
| Models, Biological | 1 | 2016 | 9907 | 0.050 |
Why?
|
| Lipopolysaccharides | 2 | 2019 | 2264 | 0.050 |
Why?
|
| Lipid Metabolism | 2 | 2022 | 1999 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 2716 | 0.050 |
Why?
|
| Academies and Institutes | 1 | 2021 | 297 | 0.040 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2019 | 92 | 0.040 |
Why?
|
| Survival Rate | 2 | 2014 | 13202 | 0.040 |
Why?
|
| Phosphorus | 1 | 2020 | 357 | 0.040 |
Why?
|
| Skilled Nursing Facilities | 1 | 2022 | 326 | 0.040 |
Why?
|
| Societies, Medical | 3 | 2020 | 3776 | 0.040 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2017 | 83 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2016 | 12366 | 0.040 |
Why?
|
| Guidelines as Topic | 2 | 2011 | 1418 | 0.040 |
Why?
|
| Time Factors | 7 | 2020 | 41038 | 0.040 |
Why?
|
| Catheters, Indwelling | 1 | 2020 | 423 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 2002 | 1156 | 0.040 |
Why?
|
| International Normalized Ratio | 1 | 2019 | 364 | 0.040 |
Why?
|
| Anthropometry | 2 | 2015 | 1367 | 0.040 |
Why?
|
| Severity of Illness Index | 3 | 2016 | 16008 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2021 | 761 | 0.040 |
Why?
|
| Filtration | 1 | 2018 | 234 | 0.040 |
Why?
|
| Gastrointestinal Contents | 1 | 2017 | 33 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2019 | 4466 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2005 | 2789 | 0.040 |
Why?
|
| alpha-Linolenic Acid | 1 | 2017 | 147 | 0.040 |
Why?
|
| Nutritional Sciences | 1 | 2018 | 145 | 0.040 |
Why?
|
| Birth Weight | 2 | 2016 | 1893 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2008 | 6765 | 0.040 |
Why?
|
| Magnesium | 1 | 2020 | 852 | 0.040 |
Why?
|
| Evidence-Based Practice | 1 | 2021 | 503 | 0.040 |
Why?
|
| Pilot Projects | 3 | 2018 | 7994 | 0.040 |
Why?
|
| Rats | 3 | 2022 | 25094 | 0.040 |
Why?
|
| Safflower Oil | 1 | 2015 | 30 | 0.040 |
Why?
|
| Body Weight | 2 | 2018 | 4680 | 0.040 |
Why?
|
| Language Development | 1 | 2017 | 196 | 0.040 |
Why?
|
| Gastrointestinal Transit | 1 | 2017 | 101 | 0.040 |
Why?
|
| Micelles | 1 | 2017 | 221 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 819 | 0.040 |
Why?
|
| Potassium | 1 | 2020 | 1375 | 0.040 |
Why?
|
| Solutions | 2 | 2011 | 417 | 0.030 |
Why?
|
| Infant Food | 1 | 1995 | 147 | 0.030 |
Why?
|
| Gastroparesis | 1 | 2017 | 121 | 0.030 |
Why?
|
| Vietnam | 1 | 2016 | 385 | 0.030 |
Why?
|
| Dietetics | 1 | 2014 | 36 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2015 | 39038 | 0.030 |
Why?
|
| Bile Acids and Salts | 1 | 2017 | 349 | 0.030 |
Why?
|
| Patient Care Team | 2 | 2022 | 2587 | 0.030 |
Why?
|
| Drug Labeling | 1 | 2017 | 258 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2008 | 10507 | 0.030 |
Why?
|
| Pulmonary Ventilation | 1 | 2016 | 376 | 0.030 |
Why?
|
| Motor Skills | 1 | 2017 | 519 | 0.030 |
Why?
|
| Eating | 1 | 2020 | 1443 | 0.030 |
Why?
|
| Hospital Bed Capacity, 300 to 499 | 1 | 1993 | 62 | 0.030 |
Why?
|
| Vomiting | 1 | 2017 | 626 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2006 | 2759 | 0.030 |
Why?
|
| Transplantation, Homologous | 2 | 2012 | 4831 | 0.030 |
Why?
|
| Remission Induction | 1 | 2019 | 2399 | 0.030 |
Why?
|
| Acetaminophen | 1 | 2017 | 540 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2016 | 623 | 0.030 |
Why?
|
| Organ Size | 1 | 2018 | 2317 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 1399 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2013 | 311 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 2455 | 0.030 |
Why?
|
| Membrane Lipids | 1 | 2013 | 253 | 0.030 |
Why?
|
| Automation | 1 | 2014 | 589 | 0.030 |
Why?
|
| Bacteria | 2 | 2000 | 2040 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2013 | 3156 | 0.030 |
Why?
|
| Boston | 2 | 2016 | 9402 | 0.030 |
Why?
|
| Diarrhea, Infantile | 1 | 2011 | 127 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2022 | 13536 | 0.030 |
Why?
|
| Education, Medical, Continuing | 1 | 2017 | 868 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 2000 | 1423 | 0.030 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2012 | 386 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2013 | 1472 | 0.030 |
Why?
|
| Checklist | 1 | 2018 | 781 | 0.030 |
Why?
|
| Instillation, Drug | 1 | 2010 | 34 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2017 | 2877 | 0.030 |
Why?
|
| Lung | 2 | 2022 | 9706 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2006 | 3609 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2017 | 1147 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2015 | 1670 | 0.030 |
Why?
|
| Platelet Count | 1 | 2013 | 794 | 0.030 |
Why?
|
| Abdomen | 1 | 2017 | 1094 | 0.030 |
Why?
|
| Feces | 1 | 2017 | 1365 | 0.030 |
Why?
|
| Inclusion Bodies | 1 | 2011 | 277 | 0.030 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2016 | 568 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2017 | 1019 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2012 | 308 | 0.020 |
Why?
|
| Adipogenesis | 1 | 2012 | 349 | 0.020 |
Why?
|
| Vitamin D | 2 | 2015 | 3138 | 0.020 |
Why?
|
| Spleen | 1 | 2016 | 2473 | 0.020 |
Why?
|
| Calorimetry, Indirect | 1 | 2010 | 178 | 0.020 |
Why?
|
| Workflow | 1 | 2014 | 803 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2017 | 2502 | 0.020 |
Why?
|
| Reference Standards | 1 | 1993 | 992 | 0.020 |
Why?
|
| Critical Care | 1 | 2022 | 2473 | 0.020 |
Why?
|
| Milk | 1 | 2012 | 430 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2000 | 6562 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 11239 | 0.020 |
Why?
|
| Middle Aged | 3 | 2020 | 213752 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2011 | 15053 | 0.020 |
Why?
|
| Probiotics | 1 | 2012 | 339 | 0.020 |
Why?
|
| Disease Progression | 2 | 2016 | 13298 | 0.020 |
Why?
|
| Arginine | 1 | 2012 | 944 | 0.020 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2008 | 62 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2010 | 200 | 0.020 |
Why?
|
| Cognition | 2 | 2017 | 5982 | 0.020 |
Why?
|
| Pharmaceutical Preparations | 1 | 1997 | 1040 | 0.020 |
Why?
|
| Data Collection | 1 | 1997 | 3276 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2013 | 2000 | 0.020 |
Why?
|
| Milk, Human | 1 | 2012 | 464 | 0.020 |
Why?
|
| Germany | 1 | 2009 | 791 | 0.020 |
Why?
|
| Siblings | 1 | 2012 | 806 | 0.020 |
Why?
|
| Caloric Restriction | 1 | 2010 | 348 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2019 | 4316 | 0.020 |
Why?
|
| Linear Models | 1 | 2017 | 5986 | 0.020 |
Why?
|
| Quality of Life | 1 | 2007 | 11594 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2006 | 6395 | 0.020 |
Why?
|
| Fibrosis | 1 | 2013 | 1947 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 13714 | 0.020 |
Why?
|
| Trace Elements | 1 | 2007 | 199 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 23020 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 9774 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2013 | 9754 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2017 | 2421 | 0.020 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2014 | 952 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2011 | 1692 | 0.020 |
Why?
|
| Gestational Age | 1 | 2014 | 3378 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2013 | 3944 | 0.020 |
Why?
|
| Medical Errors | 1 | 2014 | 1300 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 3518 | 0.020 |
Why?
|
| Europe | 1 | 2012 | 3104 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2014 | 2524 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2008 | 39292 | 0.020 |
Why?
|
| Antioxidants | 1 | 2013 | 1678 | 0.020 |
Why?
|
| Premature Birth | 1 | 2016 | 1498 | 0.020 |
Why?
|
| Internet | 1 | 2017 | 3074 | 0.020 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2006 | 227 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2010 | 2680 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2018 | 2952 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2004 | 12005 | 0.020 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2004 | 139 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2010 | 1817 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2011 | 1273 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8896 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2019 | 15274 | 0.010 |
Why?
|
| Mice, Obese | 1 | 2004 | 451 | 0.010 |
Why?
|
| Gastrointestinal Agents | 1 | 2007 | 497 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2018 | 4266 | 0.010 |
Why?
|
| Pediatrics | 1 | 2018 | 3554 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2018 | 3733 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2019 | 23950 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12447 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 2559 | 0.010 |
Why?
|
| Prognosis | 2 | 2016 | 28919 | 0.010 |
Why?
|
| Comorbidity | 1 | 2016 | 10339 | 0.010 |
Why?
|
| Necrosis | 1 | 2006 | 1646 | 0.010 |
Why?
|
| Neutrophils | 1 | 2015 | 3867 | 0.010 |
Why?
|
| Retina | 1 | 2012 | 2649 | 0.010 |
Why?
|
| Cholesterol | 1 | 2010 | 2866 | 0.010 |
Why?
|
| Rabbits | 1 | 2008 | 5163 | 0.010 |
Why?
|
| Biopsy | 1 | 2013 | 6766 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 1993 | 2277 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2016 | 8992 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2010 | 2351 | 0.010 |
Why?
|
| Hematologic Neoplasms | 1 | 2012 | 1687 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 1333 | 0.010 |
Why?
|
| Sex Factors | 1 | 2015 | 10566 | 0.010 |
Why?
|
| Hospitalization | 2 | 2016 | 9644 | 0.010 |
Why?
|
| Prevalence | 1 | 2017 | 14712 | 0.010 |
Why?
|
| Obesity | 1 | 2022 | 12031 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2004 | 1843 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 8593 | 0.010 |
Why?
|
| Protoplasts | 1 | 1997 | 43 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 8024 | 0.010 |
Why?
|
| Mycoses | 1 | 2000 | 368 | 0.010 |
Why?
|
| Massachusetts | 1 | 2009 | 8712 | 0.010 |
Why?
|
| Sepsis | 1 | 2010 | 2449 | 0.010 |
Why?
|
| Aged | 2 | 2020 | 161488 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 19423 | 0.010 |
Why?
|
| Reconstructive Surgical Procedures | 1 | 2007 | 2137 | 0.010 |
Why?
|
| Medical Records | 1 | 2000 | 1410 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2000 | 1900 | 0.010 |
Why?
|
| Research Design | 1 | 2010 | 5833 | 0.010 |
Why?
|
| Cell Wall | 1 | 1997 | 451 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 1997 | 2244 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2000 | 5235 | 0.000 |
Why?
|
| Brain | 1 | 2012 | 24969 | 0.000 |
Why?
|
| Algorithms | 1 | 2002 | 13647 | 0.000 |
Why?
|
| Neoplasms | 1 | 2010 | 20172 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 34151 | 0.000 |
Why?
|